{"id":"W4319058509","doi":"10.1007/s00415-023-11560-1","title":"Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)","year":2023,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"PTC Therapeutics; F. Hoffmann-La Roche; Spinal Muscular Atrophy Foundation","keywords":"Medicine; SMA*; Placebo; Spinal muscular atrophy; Clinical endpoint; Population; Internal medicine; Physical therapy; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134158,0.0006806913,0.001977531,0.000306975,0.0003142387,0.0005019646,0.0004053579,0.0009805715,0.002085898],"category_scores_gemma":[0.001315955,0.00028576,0.001614668,0.0002399118,0.0003143274,0.0006157074,0.0002651767,0.001625099,0.0005025457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004573794,"about_ca_system_score_gemma":0.0004835333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005580396,"about_ca_topic_score_gemma":0.001208957,"domain_scores_codex":[0.999541,0.000169879,0.00004789441,0.00008729214,0.00005903362,0.0000949878],"domain_scores_gemma":[0.9990995,0.0001795619,0.0002908847,0.00006253218,0.0000983605,0.0002692436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8240094,0.02208147,0.02258124,0.0009371572,0.00219704,0.0003955403,0.0002728401,0.0009898324,0.01617229,0.00005539971,0.001476024,0.1088318],"study_design_scores_gemma":[0.1602937,0.6948822,0.135698,0.00008518559,0.001875442,0.0003780295,0.0001231717,0.001636448,0.003258052,0.0001087295,0.001589645,0.00007131525],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954314,0.00275331,0.0001995937,0.00009601321,0.00004555861,0.0002448313,0.0004097323,0.00005735261,0.0007621598],"genre_scores_gemma":[0.9969544,0.0007285785,0.0002378343,0.0002848117,0.0000710297,0.0002911038,0.0006335241,0.000005424501,0.0007931965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002085898,"threshold_uncertainty_score":0.007095039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01643771123829728,"score_gpt":0.3044160053314067,"score_spread":0.2879782940931094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}